期刊文献+

血浆和肽素、N末端脑钠肽前体和肾上腺髓质素前体N端20肽与慢性心力衰竭的关系研究 被引量:10

Relationship between plasma copeptin,proadrenomedullin N-terminal 20 peptide,N-terminal pro-brain natriuretic peptide levels and chronic heart failure
下载PDF
导出
摘要 目的:探讨血浆和肽素、肾上腺髓质素前体N端20肽(proadrenomedullin N-terminal 20 peptide,PAMP)、N末端脑钠肽前体(N-terminal pro-brain natriuretic peptide,NT-proBNP)水平和慢性心力衰竭(chronic heart failure,CHF)及其严重程度的相关关系。方法:分别入选CHF患者72例和32例非CHF对照,检测纳入对象血浆和肽素、PAMP和NT-proBNP水平,心脏彩超评价心脏的结构和功能。结果:CHF患者血浆和肽素、NT-proBNP水平与对照组相比明显升高(P<0.001),并随纽约心脏病协会(New York heart association,NYHA)分级的增加而升高。和肽素分别与左室舒张末期内径值(r=0.508)、血肌酐(r=0.320)、NYHA分级(r=0.567)、NT-proBNP(r=0.412)呈显著正相关(均有P<0.01),与左室射血分数呈负相关(r=-0.663,P<0.01)。CHF患者血浆PAMP水平与对照组相比无显著差异。结论:血浆和肽素、NT-proBNP水平在CHF中显著升高,并与CHF的严重程度密切相关。 Objective:To investigate the relationship between plasma copeptin, proadrenomedullin N-terminal 20 peptide (PAMP), N- terminal pro-brain natriuretic peptide(NT-proBNP) levels and severity of chronic heart failure(CHF). Methods :Seventy-two patients with CHF and 32 non-CHF controls were enrolled. Plasma copeptin and PAMP concentrations were measured by ELISA and concen- tration of NT-proBNP was detected by triaged detection instrument. Cardiac structure and function were evaluated by color Doppler ultrasound. Results:Plasma copeptin and NT-proBNP levels were significantly higher in patients with CHF than in non-CHF controls (P〈0.001) ,which were elevated with the increase of the New York heart association(NYHA) class. Concentration of copeptin was posi- tively correlated with left ventricular end-diastolic diameter (LVEDD) (r=0.508), serum creatinine (r=0.320), NYHA class (r=0.567), NT-proBNP(r=0.412) (all P〈0.01) and was negatively correlated with left ventricular ejection fraction(r=-0.663,P〈0.01). There was no significant difference in terms of plasma PAMP levels between patients with CHF and non-CHF controls. Conclusions : Plasma copeptin and NT-proBNP levels are higher in patients with CHF and are closely related with the severity of CHF.
出处 《重庆医科大学学报》 CAS CSCD 北大核心 2013年第5期534-537,共4页 Journal of Chongqing Medical University
基金 重庆市卫生局面上资助项目(编号:2011-2-547)
关键词 慢性心力衰竭 和肽素 肾上腺髓质素前体N端20肽 N末端脑钠肽前体 chronic heart failure copeptin proadrenomedullin N-terminal 20 peptide N-terminal pro-brain natriuretic peptide
  • 相关文献

参考文献12

  • 1McMurray J J,Adamopoulos S,Anker S D,et akESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology.developed in collaboration with the Heart Failure Association (HFA) of the ESC[J]. Eur Heart J, 2012,33 (14) : 1787-1847.
  • 2Maisel A,Mueller C,Adams K J,et al.State of the art: using na- triuretic peptide levels in clinical practice[J].Eur J Heart Fail, 2005,10 (9) : 824-839.
  • 3Neuhold S,Huelsmann M,Strunk G,et al.Comparison of copeptiu,B-type natriuretic peptide,and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease[J].J Am Coil Cardiol,2008,52 (4):266- 272.
  • 4Miller W L,Hartman K A,Grill D E,et al.Serial measurements of midregion proANP and eopeptin in ambulatory patients with heart fail- ure: incremental prognostic value of novel biomarkers in heart failure [J].Heart, 2012,98 (5) : 389-394.
  • 5高玉琪,李志樑,吴宏超,钟萍,陆青,严全能,唐朝枢.心力衰竭患者肾上腺髓质素和前体N端20肽的改变[J].第一军医大学学报,2002,22(7):630-634. 被引量:2
  • 6Goldsmith S R,Gheorghiade M.Vasopressin antagonism in heart fail- ure[J].J Am Coil Cardiol, 2005,46( 10):1785-1791.
  • 7Chatterjee K.Neurohormonal activation in congestive heart failure and the role of vasopressin[J].Am J Cardiol, 2005,95 (9A) : 8B- 13B.
  • 8李晓涛,夏岳,郭喜朝,魏立业,戚国庆.血浆和肽素、B型利钠肽水平与慢性心力衰竭的关系[J].临床心血管病杂志,2011,27(4):268-270. 被引量:62
  • 9Vondrakova D, Malek F, Ostadal P, et al.Correlation of NT-proB- NP,proANP and novel biomarkers:copeptin and proadrenomedullin with LVEF and NYHA in patients with ischemic CHF,non-ischemic CHF and arterial hypertension[J].Int J Cardiol, 2011,150 (3) : 343-344.
  • 10Eto T.A review of the biological properties and clinical implica- tions of adrenomedullin and proadrenomedullin N-terminal 20 peptide (PAMP),hypotensive and vasodilating peptides[J].Peptides,2001,22 (11):1693-1711.

二级参考文献19

  • 1[1]Mckee P, Castell W, Mcnamara P, et al. The natural history of congestive heart failure, the Framingham study[J]. N Engl J Med, 1971,285(26): 1441-6.
  • 2[2]Marantz P, Tobin J, Wassertheil S, et al. The relationship between left ventricular systolic function and congestive heart failure diagnosed by clinical criteria[J]. Circulation, 1988, 77(3): 607-12.
  • 3[3]Baig MK, Mahon N, McKenna WJ, et al. The pathophysiology of advanced heart failure[J].Am Heart J, 1998, 135(6 Pt 2 Su): S216-30.
  • 4[4]New RB, Sampson AC, King MK, et al. Effects of combined angiotensin Ⅱ and endothelin receptor blockade with developing heart failure: effects on left ventricular performance [J]. Circulation, 2000,102(12): 1447-53.
  • 5[5]Ishiyama T, Kato J, Kitamura K, et al. Production of adrenomedullin in human vascular endothelial cells [J]. Life Sci, 1997, 60(20):1763-9.
  • 6[6]Sugo S, Minamino N, Shoji N, et al. Production and secretion of adrenomedullin from vascular smooth muscle cells: augmented production by tumor necrosis factor-alpha [J]. Biochem Biophys Res Commun, 1994, 203(1): 719-26.
  • 7[7]Kitamura K, Kanawa K, Kawamoto M, et al. Adrenomedullin: a noval hypertensive peptide isolated from human pheochromocytoma[J]. Biochem Biophys Res Commun, 1993, 192(2): 553-6.
  • 8[8]Niina H, Kobayashi H, Kitamura K, et al. Inhibition ofcatecholamine synthesis by proadrenomedullin N-terminal 20 peptide in cultured bovine adrenal medullary cells[J]. J Neurochem, 1995, 286 (1): 95-7.
  • 9[9]Shimosawa T, Ito Y, Ando K, et al. Proadrenomedullin NH2-terminal 20 peptide, a new product of the adrenomedullin gene, inhibits norepinephrine overflow from nerve endings[J]. J Clin Invest, 1995,96(3): 1672-6.
  • 10[10]Etoh T, Kato J, Takenaga M, et al. Differential hormonal profile of adrenomedullin and preadrenomedullin N- terminal 20 peptide in patients with heart failure and effect of treatment on their plasma levels[J]. Clin Cardiol, 1999, 22(2): 113-7.

共引文献62

同被引文献82

引证文献10

二级引证文献61

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部